State Street’s Arcadia Biosciences RKDA Stock Holding History

State Street’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.25K	Hold	12,146	–	–	﹤0.01%	4170
2026 Q1	$16.8K	Hold	12,146	–	–	﹤0.01%	4228
2025 Q4	$24K	Hold	12,146	–	–	﹤0.01%	4233
2025 Q3	$42.1K	Hold	12,146	–	–	﹤0.01%	4174
2025 Q2	$53.6K	Hold	12,146	–	–	﹤0.01%	4085
2025 Q1	$34.5K	Hold	12,146	–	–	﹤0.01%	4143
2024 Q4	$71.9K	Hold	12,146	–	–	﹤0.01%	4059
2024 Q3	$34K	Hold	12,146	–	–	﹤0.01%	4162
2024 Q2	$38.3K	Hold	12,146	–	–	﹤0.01%	4191
2024 Q1	$26.4K	Hold	12,146	–	–	﹤0.01%	4256
2023 Q4	$36.8K	Hold	12,146	–	–	﹤0.01%	4255
2023 Q3	$40.3K	Hold	12,146	–	–	﹤0.01%	4335
2023 Q2	$47.1K	Hold	12,146	–	–	﹤0.01%	4434
2023 Q1	$90.7K	Buy	12,146 +9,601	+377%	+$102K	﹤0.01%	4346
2022 Q4	$27.6K	Sell	2,545 -3	-0.1%	-$43	﹤0.01%	4680
2022 Q3	$54K	Hold	2,548	–	–	﹤0.01%	4640
2022 Q2	$102K	Buy	2,548 +63	+3%	+$2.9K	﹤0.01%	4529
2022 Q1	$139K	Buy	2,485 +1,079	+77%	+$51.5K	﹤0.01%	4521
2021 Q4	$58K	Hold	1,406	–	–	﹤0.01%	4673
2021 Q3	$116K	Buy	1,406 +498	+55%	+$46.7K	﹤0.01%	4509
2021 Q2	$108K	Buy	+908	New	+$99K	﹤0.01%	4347

Other funds holding RKDA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BWM

Bullock Wealth Management Bloomington, Indiana $231M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

State Street's RKDA Position: Q2 2026 in Review

State Street held its Arcadia Biosciences (RKDA) position steady in Q2 2026 at 12,146 shares worth $8.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4170.

State Street first reported a position in RKDA in Q2 2021 and has held it in 21 quarters since. The position peaked at $139K in Q1 2022. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

State Street held 12,146 shares of Arcadia Biosciences worth $8.25K as of Q2 2026.
State Street left its Arcadia Biosciences share count unchanged in Q2 2026.
Arcadia Biosciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4170 holding.
State Street first reported a position in Arcadia Biosciences in Q2 2021 and has held it in 21 quarters since.
State Street's Arcadia Biosciences position peaked at $139K in Q1 2022.
18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.